67 years after John Gielgud played the part here and prophesied that after him this great theatre would be “lost to musicals” and never again host Shakespeare. That Weaver’s Tempest is now ...
March 13, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight ...